Home » Topics » BioWorld Science

BioWorld Science
RSS

Faron receives regulatory approval to initiate first-in-human MATINS study of Clevegen

Dec. 4, 2018

Lilly opens phase II study of LY-3209590 for type 2 diabetes

Dec. 4, 2018

FIT free lunch

Dec. 4, 2018

Abrogating androgen axis of evil

Dec. 4, 2018

Gene therapy rewires brain in PD

Dec. 4, 2018

Breathing control can be restored long after SCI

Dec. 4, 2018

New phase II investigator-initiated study evaluates nitazoxanide in NASH-induced fibrosis

Dec. 3, 2018

FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain

Dec. 3, 2018

Phase III ERADICATE Hp2 study of Talicia meets primary endpoint of H. pylori eradication

Dec. 3, 2018

Sienna reports phase IIb topline data on SNA-120 in psoriasis

Dec. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...